Diffusion-Weighted MRI in Multiple Sclerosis: A Study with Human Subjects
A study involving 50 human participants with multiple sclerosis used diffusion-weighted magnetic resonance imaging to measure IVIM parameters like ADC, D, D*, and f in brain regions. However, no results have been posted yet, and the endpoints planned for the study remain unreported.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- No results yet
- Outcome
- Not reported
Why it matters
Understanding how these imaging parameters relate to multiple sclerosis could inform future diagnostic and monitoring strategies, although current findings do not provide conclusions.
What this does not prove
The lack of results means we can't draw any conclusions about the intervention's effectiveness or impact on patients. Planned enrollment and endpoints are not findings themselves.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 50 · actual
- Randomised
- Not applicable
- Controlled
- No
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (16)
limitationsPlanned enrolment and endpoints are not findings.
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years; sex All
speciesParticipants: people; ages from 18 Years; sex All
sample sizeEnrollment: 50 participants (actual)
sample size basisEnrollment: 50 participants (actual)
randomizedAllocation: Not applicable
peer reviewedPublication date: unknown.
relevant ms typesConditions: Multiple Sclerosis
interventionInterventions: Diffusion-weighted magnetic resonance imaging
primary endpointPrimary endpoints: IVIM parameters (including ADC,D,D*,f) in Multiple Sclerosis brain regions.
follow upFollow-up: Up to 2 months
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
controlledIntervention model: Single group
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.